PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21 | +110.0% | 8,100 | +406.2% | 0.00% | +100.0% |
Q2 2023 | $10 | +42.9% | 1,600 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $7 | -50.0% | 1,600 | -5.9% | 0.00% | 0.0% |
Q4 2022 | $14 | -99.9% | 1,700 | -37.0% | 0.00% | -50.0% |
Q3 2022 | $25,000 | -86.3% | 2,700 | -88.2% | 0.00% | -83.3% |
Q2 2022 | $182,000 | +5966.7% | 22,791 | +776.6% | 0.01% | – |
Q2 2021 | $3,000 | – | 2,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |